-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LcRFVW1xUcf6RqqV4d7ZTPAigZYUQ7NhTckwjWunQFNhkK7SGYIiKeU4uOjInFt1 U7sSUXu90RvDL/hynVfwGg== 0001191076-05-000004.txt : 20050217 0001191076-05-000004.hdr.sgml : 20050217 20050217180418 ACCESSION NUMBER: 0001191076-05-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050217 FILED AS OF DATE: 20050217 DATE AS OF CHANGE: 20050217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOBDEN ADRIAN N CENTRAL INDEX KEY: 0001191076 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 05625191 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-02-17 0 0000899923 MYRIAD GENETICS INC MYGN 0001191076 HOBDEN ADRIAN N 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 Pres. Myriad Pharmaceuticals Incentive Stock Option (right to buy) 22.12 2005-02-17 4 A 0 4520 0 A 2015-02-17 Common Stock 4520 4520 D Non-Qualified Stock Option (right to buy) 22.12 2005-02-17 4 A 0 40480 0 A 2015-02-17 Common Stock 40480 40480 D The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. By: Jay M. Moyes For: Adrian N. Hobden 2005-02-17 -----END PRIVACY-ENHANCED MESSAGE-----